Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.6.1 instead of v3.6.0, reflecting a small internal update to the page version with no visible content changes.SummaryDifference0.0%

- Check13 days agoChange DetectedRecruitment for the study is closed as indicated by 'No longer looking for participants'. New help and navigation sections have been added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with labeling updates to sections such as Intervention/Treatment.SummaryDifference0.2%

- Check21 days agoChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a minor update to the page metadata. This update does not introduce visible content changes.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page revision tag changed from v3.5.3 to v3.5.4, indicating a minor update to the ClinicalTrials.gov record. There are no visible changes to the study content (inclusion/exclusion criteria, endpoints, or locations) in this update.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a newer iteration. This is a minor update to the page's version and does not alter study content or how the page operates.SummaryDifference0.0%

- Check70 days agoChange DetectedSite revision updated to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.